The POLR1D gene plays a crucial role in the genetic landscape of Treacher Collins Syndrome Type 2 (TCS2), a condition characterized by craniofacial deformities that are present from birth. This condition is part of a spectrum of disorders affecting facial bone and tissue development, leading to anomalies in the ears, eyes, cheekbones, and chin. The genetic test for POLR1D associated with Treacher Collins Syndrome Type 2 is a sophisticated diagnostic tool aimed at identifying mutations within the POLR1D gene, which are indicative of the syndrome.
Conducted at DNA Labs UAE, this genetic test is a pivotal step in diagnosing TCS2, enabling healthcare providers to offer targeted treatment and interventions. With a cost of 4400 AED, the test is accessible to those who suspect they or their family members may be affected by this genetic condition. Early diagnosis through the POLR1D gene test can significantly impact the management of the syndrome, offering insights into potential complications and guiding both surgical and non-surgical treatment plans tailored to the individual's specific needs.
The POLR1C gene is associated with Treacher Collins Syndrome Type 3 (TCS3), a rare genetic disorder characterized by craniofacial deformities. TCS3 is a condition that affects the development of bones and other tissues of the face, leading to features such as underdeveloped facial bones, cleft palate, and hearing loss. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
A genetic test for the POLR1C gene can help in the diagnosis of Treacher Collins Syndrome Type 3. This test is particularly crucial for families with a history of the condition or for individuals showing symptoms related to TCS3. Early diagnosis through genetic testing can enable timely intervention and management of the disorder, improving the quality of life for affected individuals.
In the United Arab Emirates, DNA Labs UAE offers a specific genetic test for the POLR1C gene to diagnose Treacher Collins Syndrome Type 3. The test is priced at 4400 AED. DNA Labs UAE is equipped with advanced technology and staffed by professionals specialized in genetic analysis, ensuring accurate and reliable test results. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab to detect mutations in the POLR1C gene that are indicative of TCS3.
This genetic test is an important tool for individuals and families seeking answers about Treacher Collins Syndrome Type 3, providing them with crucial information for making informed decisions about their health and future.
The FGFR1 Gene Trigonocephaly Type 1 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the FGFR1 gene, which are associated with Trigonocephaly Type 1, a rare genetic disorder characterized by a triangularly shaped forehead caused by the premature fusion of the metopic suture. This condition may lead to developmental delays, cognitive impairment, and physical deformities. The test is crucial for early diagnosis and intervention, allowing for tailored treatment and management plans for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the FGFR1 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately.
Early diagnosis through the FGFR1 Gene Trigonocephaly Type 1 Genetic Test can significantly impact the quality of life for individuals with this condition, guiding healthcare professionals in providing the most effective treatments and support for managing symptoms and preventing complications.
The WNT7A gene plays a critical role in the development of limbs and is associated with various genetic conditions that affect limb formation. One such condition involves the absence of the ulna and fibula bones, leading to severe limb deficiency. This rare genetic disorder is characterized by significant abnormalities in limb development, which can impact the quality of life of affected individuals.
To diagnose this condition, genetic testing focusing on the WNT7A gene can be conducted. DNA Labs UAE offers a specialized genetic test designed to identify mutations in the WNT7A gene that are linked to the absence of ulna and fibula bones with severe limb deficiency. This test is crucial for confirming the diagnosis, understanding the severity of the condition, and guiding treatment and management strategies for affected individuals and their families.
The cost of the genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of specific genetic mutations in the WNT7A gene. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of the condition, enabling informed decisions about care and support.
It's important to consult with a healthcare professional or a genetic counselor before undergoing any genetic testing to understand the implications of the test results and the best course of action based on those results.
The TBX3 Gene Ulnar-Mammary Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the TBX3 gene, which are associated with Ulnar-Mammary Syndrome (UMS). UMS is a rare genetic condition characterized by abnormalities in the development of the ulna (one of the long bones in the forearm), the mammary gland, and other bodily structures. Symptoms can include limb anomalies, underdeveloped or absent pectoral muscles, dental issues, and hormonal deficiencies affecting growth and development.
This genetic test is crucial for individuals displaying symptoms suggestive of UMS, or for those with a family history of the condition, as it can provide definitive diagnosis. Early diagnosis through the TBX3 gene test can aid in the management and treatment of symptoms, and also provide valuable information for family planning.
The cost of the TBX3 Gene Ulnar-Mammary Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expertise and technology required to accurately identify the presence of mutations in the TBX3 gene, providing patients and their families with essential genetic insights into this rare condition.
The LRIG2 gene urofacial syndrome genetic test is a specialized diagnostic tool used to identify mutations in the LRIG2 gene, which are associated with urofacial syndrome. Urofacial syndrome, also known as Ochoa syndrome, is a rare genetic condition characterized by abnormal facial expressions and urinary tract malformations. This syndrome can lead to severe urinary and kidney problems if not diagnosed and managed properly.
The test involves analyzing the patient's DNA to look for specific mutations in the LRIG2 gene that are linked to the development of urofacial syndrome. Early identification of these mutations allows for timely intervention and management strategies to mitigate the impact of the syndrome on the patient's health and quality of life.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the LRIG2 gene urofacial syndrome genetic test is priced at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and healthcare professionals, ensuring accurate and reliable test results. By opting for this test at DNA Labs UAE, individuals suspected of having urofacial syndrome can gain crucial insights into their condition, enabling them and their healthcare providers to make informed decisions about their treatment and management.
The HPSE2 Gene Urofacial Syndrome Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the HPSE2 gene, which are associated with Urofacial Syndrome Type 1 (UFS1). This condition, also known as Ochoa syndrome, is a rare genetic disorder characterized by an abnormal facial expression and difficulties with urinary tract function. Symptoms often include a distinctive facial grimace when attempting to smile and various degrees of urinary tract problems, which can lead to serious kidney damage if left untreated.
The test, available at DNA Labs UAE, is crucial for the early detection and management of UFS1. It involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the HPSE2 gene. Identifying these mutations can confirm a diagnosis of Urofacial Syndrome Type 1, allowing for appropriate medical interventions and genetic counseling for affected families.
The cost of the HPSE2 Gene Urofacial Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment can be invaluable for families seeking answers to unexplained urinary and facial symptoms in their loved ones, paving the way for targeted treatments and improved quality of life for individuals with UFS1.
The SCARF2 gene Van den Ende-Gupta syndrome genetic test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the SCARF2 gene, which are associated with Van den Ende-Gupta syndrome (VEGS). This rare genetic disorder is characterized by craniofacial, skeletal, and limb abnormalities, with patients often presenting with features such as malar hypoplasia, arachnodactyly, and camptodactyly, among others. The test aims to provide a definitive diagnosis for individuals displaying symptoms suggestive of VEGS, facilitating appropriate management and genetic counseling.
Performed at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the SCARF2 gene. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided by the lab.
This genetic test is crucial for affected families, as it not only confirms the diagnosis but also aids in understanding the inheritance patterns and potential risks for future offspring. Early diagnosis through the SCARF2 gene test can lead to better management of the syndrome's symptoms and improvements in the quality of life for those affected.
The "IRF6 Gene Van der Woude Syndrome Type 1 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the IRF6 gene, which are known to cause Van der Woude Syndrome Type 1. This condition is the most common syndromic form of cleft lip and palate, characterized by orofacial anomalies, including lip pits and clefts of the lip and/or palate. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect mutations in the IRF6 gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families. By pinpointing the specific genetic alterations, healthcare providers can offer personalized treatment plans and support for those diagnosed with Van der Woude Syndrome Type 1, enhancing the quality of life for patients and assisting in the understanding of the genetic basis of the condition.
The GRHL3 gene test for Van der Woude Syndrome Type 2 is a specialized genetic examination designed to identify mutations in the GRHL3 gene, which are implicated in the development of Van der Woude Syndrome Type 2 (VWS2). VWS2 is a rare genetic disorder characterized by distinctive facial features, including cleft lip and/or palate, pits or mounds of the lower lip, and sometimes missing teeth or other dental abnormalities. The condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
This genetic test is crucial for families with a history of VWS2, as it can provide definitive confirmation of the diagnosis, inform clinical management, and guide genetic counseling. Early diagnosis through genetic testing can significantly benefit affected individuals, allowing for timely intervention and support for associated symptoms.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the GRHL3 gene test for Van der Woude Syndrome Type 2 at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the GRHL3 gene. Upon completion, the results from this test can offer valuable insights for affected individuals and their families, aiding in the management of the condition and planning for future family planning decisions.
